Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GE Healthcare

Division of General Electric Co.
www.gehealthcare.com

Latest From GE Healthcare

Global Device Approvals Snapshot: 9-15 July 2019; MitraClip G4, Relievion, RAPID Imaging, ExAblate Neuro

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. The week of 9-15 July was another slow one for US FDA approvals, with no new PMAs, panel-track PMA supplements, or de novos. Informa’s Meddevicetracker reported three non-US approvals during the week.

Approvals Innovation

Start-Up Spotlight: Distalmotion Wants To Bring Cost-Effective, Focused Alternative To Robotic Surgery Market

Switzerland-based Distalmotion hopes to make its Dexter robotic surgery the standard of care in procedures that entail precise dissection and suturing and market itself as a more cost-effective alternative to Intuitive Surgical’s da Vinci system.

Start-up Spotlight Innovation

Bracco Boosts Precision Medicine Portfolio With $450M Deal For Blue Earth

Bracco Imaging is paying $450m to buy Blue Earth Diagnostics from London-listed venture capital firm Syncona Investment Management Ltd.

M & A Diagnostics

Exec Chat: Philips's Bert Van Meurs Discusses Innovation And Plans For Image-Guided Therapy Business Unit

This year, Bert van Meurs, chief business leader of Philips's image-guided therapy business, has led two major product launches and a new partnership with Microsoft to combine Philips's Azurion angiographic platform with Microsoft's HoloLens 2 mixed-reality (MR) technology. Medtech Insight caught up with van Meurs to learn more about Azurion, the continued role of machine learning and MR, the overall business strategy and competitive landscape.

Exec Chat Innovation
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register